Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-25-003081
Filing Date
2025-03-14
Accepted
2025-03-14 16:41:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 5806
2 GRAPHIC g847359g04l29.jpg GRAPHIC 8419
  Complete submission text file 0000950123-25-003081.txt   18685
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)